AMANF yields 4.77% · PFE yields 6.13%● Live data
📍 AMANF pulled ahead of the other in Year 1
Combined, AMANF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMANF + PFE for your $10,000?
Amano Corporation provides time information, parking, environmental, and cleaning systems in Japan, North America, and internationally. It operates through Time Information System Business and Environment System Business segments. The company's time information systems include time and attendance (T&A), payroll, human resource, and access information systems; and T&A and access information terminals, PC interfaced time recorders, time recorders, electronic time stamps, and T&A/payroll/HR cloud services. It also provides parking systems, such as gate-type, flap-lock, bicycle parking, vehicle guidance, parking lot management, and security gate systems, as well as offers parking facility data center and commissioned management services. In addition, the company offers environmental systems comprising energy and space-saving pulse-jet, all stainless steel body, and dust explosion pressure diffusion type dust collectors; electric mist collectors; dust collectors for welding work; industrial air purifiers; and volatile organic compounds removal, pneumatic powder conveying, and large-scale dust collection systems. Further, it provides cleaning systems that include compact automatic floor and ride-on automatic scrubbers; robotic vacuum, carpet, and industrial vacuum cleaners; and electrolytic water generators, electronic high-speed burnishers, hand-pushed sweepers, and floor polishers. Amano Corporation was founded in 1931 and is headquartered in Yokohama, Japan.
Full AMANF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.